News

For the treatment of MCL, a recent study found that bendamustine and rituximab was the most used frontline regimen, while BTK inhibitors were the most used agents in later lines of therapy.

Automated alerts providing recommendations in the electronic health record were shown to increase the rate of compliance with such recommendations by 5% to 10%.

Researchers describe the epidemiology, treatment, and issues in survivorship facing patients with advanced cervical cancer.

Findings from a recent study identified an unmet need for more effective first-line therapeutic options for patients with chronic lymphocytic leukemia/small lymphocytic leukemia and deletion 17p, despite the advent of ibrutinib.

A recent study found that as many as half of patients with rectal cancer do not receive proper pre-treatment staging imaging, despite NCCN guideline recommendations for such imaging.

While surgical resection alone might be an inadequate approach to controlling TGCT, new treatment options may complement surgery and alleviate the clinical and economic burden among patients with TGCT who received prior surgery.

Machine learning models that were developed from multi-institutional clinicopathologic data may reduce the number of pathologically node-negative neck dissections and accurately identify patients with early OCSCC who are at highest risk for...

Researchers at Oregon Health and Science University compared the cost, health care resource utilization, and adverse events of chimeric antigen receptor T-cell therapies for relapsed or refractory (R/R) diffuse large B-cell lymphoma.

Immune checkpoint inhibitors (ICIs) have been shown to extend progression-free survival and overall survival in patients with a variety of cancers, leading to increases in the systemic treatment of patients with advanced cancer who are near...

Researchers reviewed the National Cancer Database records of nearly 32,000 men diagnosed with UIR prostate cancer to determine if men treated with brachytherapy had rates of survival comparable with those of men treated with EBRT.